November is meant to bring awareness to men's health and the importance of getting the proper testing for various conditions. The PSA test is a blood test used to screen for prostate cancer. Elevated PSA levels may indicate prostate cancer, a noncancerous condition such as prostatitis, or an enlarged prostate.
The PSA test is a typical screening method for prostate cancer. Screening for PSA can help early identify diseases for which treatment may be more effective and potentially have fewer side effects. A PSA test may be done in conjunction with a digital rectal examination (DRE), in which a doctor inserts a gloved finger into the rectum to check for abnormalities in the prostate.
Detecting certain types of prostate cancer early can be critical. Elevated PSA results may reveal prostate cancer that's likely to spread to other parts of your body (metastasize), or they may reveal a quick-growing cancer that's likely to cause other problems.
PCF recommends that you make a shared decision about PSA screening with your doctor, starting at age 45, or age 40 if you have a family history of prostate or other cancers or are Black.
PSA screening is only the first step in telling you and your doctor that additional tests may be needed. If your PSA level is not too high, your doctor may recommend repeating the test after a few weeks. From there, other types of tests can help determine if a biopsy is needed, including:
You can now schedule a virtual consultation with one of our board-certified doctors, Physician Assistants, and Nurse Practitioners through LabFinder.
of medical decisions are based on test results*
of adults say they worry about unexpected medical bills**
a new cancer is diagnosed in the United States.***
“From start to finish, this process was simple and efficient. I was easily able to find a location for COVID testing for myself and my two kids, set up our appointments together, get tested, and receive our results quickly. I just really appreciate you all for making such a stressful situation easier for us.”
Janine T, 2021